Management of HBV and HBV/HDV-Associated Liver Cirrhosis
Author(s) -
Christoph Höner zu Siederdissen,
Markus Cornberg
Publication year - 2016
Publication title -
visceral medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.598
H-Index - 17
eISSN - 2297-475X
pISSN - 2297-4725
DOI - 10.1159/000445518
Subject(s) - cirrhosis , medicine , hepatocellular carcinoma , hepatitis b virus , hepatitis d , liver transplantation , hepatitis b , hepatitis d virus , pegylated interferon , gastroenterology , liver disease , liver function , entecavir , immunology , virus , virology , transplantation , hepatitis c virus , lamivudine , hbsag , ribavirin
Chronic hepatitis B virus (HBV) infection and hepatitis delta virus (HDV) co-infection lead to liver cirrhosis, hepatic decompensation, and hepatocellular carcinoma (HCC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom